Leon Nanodrugs Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
Leon Nanodrugs General Information
Description
Developer of drugs through nanoscience designed to offer patient outcomes. The company's drugs specialize in improving the bioavailability of poorly water-soluble medicine by using their proprietary technology to create either polymeric or crystalline nanoparticles, enabling medical professionals to get nano-formulated drugs with meaningful differentiation and added benefits.
Contact Information
Website
www.leon-nanodrugs.comCorporate Office
- Am Klopferspitz 19
- 82152 Planegg
- Germany
Corporate Office
- Am Klopferspitz 19
- 82152 Planegg
- Germany
Leon Nanodrugs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 12-Feb-2026 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 06-Aug-2024 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | Completed | Generating Revenue | ||||
| 3. Secondary Transaction - Private | 01-Jul-2020 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 16-Apr-2020 | $20.5M | Completed | Generating Revenue | ||
| 1. Later Stage VC (Series A) | 27-Jul-2015 | $20.5M | $20.5M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Leon Nanodrugs Comparisons
Industry
Financing
Details
Leon Nanodrugs Competitors (17)
One of Leon Nanodrugs’s 17 competitors is Calliditas Therapeutics France, a Corporate Backed or Acquired company based in Saint-Julien- en-Genevois, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Calliditas Therapeutics France | Corporate Backed or Acquired | Saint-Julien- en-Genevois, France | ||||
| Precision Nanosystems | Formerly VC-backed | Vancouver, Canada | ||||
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK | ||||
| Oxford Biotherapeutics | Private Equity-Backed | Oxford, United Kingdom | ||||
| Scynexis | Formerly VC-backed | Jersey City, NJ |
Leon Nanodrugs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Leon Nanodrugs Patents
Leon Nanodrugs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025228668-A1 | Method for manufacturing lipid nanoparticles | Pending | 03-May-2024 | ||
| EP-4753850-A1 | Fluid material container for aseptic manufacturing processes | Pending | 03-Aug-2023 | ||
| WO-2025027208-A1 | Fluid material container for aseptic manufacturing processes | Inactive | 03-Aug-2023 | ||
| AU-2023348363-A1 | Apparatus and method for operating a static mixing device | Pending | 30-Sep-2022 | ||
| EP-4526027-A1 | Apparatus and method for operating a static mixing device | Active | 30-Sep-2022 | B01F25/23 |
Leon Nanodrugs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Leon Nanodrugs Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LBBW Venture Capital | Corporate Venture Capital | Minority | ||
| Albany Capital (Australia) | Venture Capital | Minority | ||
| Bayerische Beteiligungsgesellschaft | Venture Capital | Minority | ||
| Eckenstein-Geigy-Stiftung | Not-For-Profit Venture Capital | Minority | ||
| Evotec | Corporation | Minority |
Leon Nanodrugs FAQs
-
When was Leon Nanodrugs founded?
Leon Nanodrugs was founded in 2010.
-
Where is Leon Nanodrugs headquartered?
Leon Nanodrugs is headquartered in Planegg, Germany.
-
What is the size of Leon Nanodrugs?
Leon Nanodrugs has 14 total employees.
-
What industry is Leon Nanodrugs in?
Leon Nanodrugs’s primary industry is Drug Discovery.
-
Is Leon Nanodrugs a private or public company?
Leon Nanodrugs is a Private company.
-
What is Leon Nanodrugs’s current revenue?
The current revenue for Leon Nanodrugs is .
-
How much funding has Leon Nanodrugs raised over time?
Leon Nanodrugs has raised $20.5M.
-
Who are Leon Nanodrugs’s investors?
LBBW Venture Capital, Albany Capital (Australia), Bayerische Beteiligungsgesellschaft, Eckenstein-Geigy-Stiftung, and Evotec are 5 of 11 investors who have invested in Leon Nanodrugs.
-
Who are Leon Nanodrugs’s competitors?
Calliditas Therapeutics France, Precision Nanosystems, Cytovance Biologics, Oxford Biotherapeutics, and Scynexis are some of the 17 competitors of Leon Nanodrugs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
